Exosomes Derived hsa-miR-4669 as a Novel Biomarker for Early Predicting the Response of Subcutaneous Immunotherapy in Pediatric Allergic Rhinitis.
Sijie JiangShaobing XieRuohao FanQingping TangHua ZhangFengjun WangShumin XieKelei GaoJunyi ZhangZhihai XieWeihong JiangPublished in: Journal of inflammation research (2022)
Serum exosomes derived miRNA were associated with the efficacy of SCIT. Serum exosomes derived hsa-miR-4669 might serve as a novel biomarker for early predicting the response of SCIT in AR children.